申请人:DAIICHI PHARMACEUTICAL CO., LTD.
公开号:EP0624584A1
公开(公告)日:1994-11-17
A compound represented by formula (I):
wherein Q represents an aryl group, a heterocyclic group, a diarylmethyl group, an aralkyl group composed of an aryl group and an alkylene group, an alkyl group or a cycloalkyl group, in which the aryl group, heterocyclic group, and the aryl moiety of the diarylmethyl group and aralkyl group may be substituted with one or more substituents; R represents a bicyclic, substituted, nitrogen-containing heterocyclic group or a substituted phenyl group, in which the nitrogen-containing heterocyclic group is composed of a 5-membered, substituted, aromatic or saturated ring containing one or two nitrogen atoms and a 6-membered ring; and Z represents an alkylene group, an alkenylene group, an alkylene group, a carbonyl group, an alkylene group containing a carbonyl group or an oxalyl group,
or a salt thereof. The compound has calmodulin inhibitory activity and is useful as a treating agent for diseases in the circulatory organs or in the cerebral region which are caused by excessive activation of calmodulin.
式 (I) 所代表的化合物:
其中 Q 代表芳基、杂环基、二芳甲基、由芳基和亚烷基组成的芳烷基、烷基或环 烷基,其中芳基、杂环基以及二芳甲基和芳烷基的芳基可被一个或多个取代基取代;R 代表双环、取代的含氮杂环基团或取代的苯基,其中含氮杂环基团由含有一个或两个氮原子的五元环、取代的芳香环或饱和环以及六元环组成;以及 Z 代表烯基、烯基、亚烷基、羰基、含有羰基的亚烷基或草酰基、
或其盐。该化合物具有钙调蛋白抑制活性,可用于治疗因钙调蛋白过度活化而引起的循环器官或脑部疾病。